Hematopoietic stem cells (HSCs) are long-lasting cells that mature into all types of blood cells: white blood cells, red blood cells and platelets. Almost a trillion new blood cells must be replaced each day to replace normal loss of old blood cells. “Bone Marrow Transplant” is a procedure currently used by clinicians to transplant HSCs and cure a wide range of blood diseases. But not all patients have a suitable donor for a HSC transplant. For the first-time ever, Dr. Joseph Scandura, Scientific Director of the Silver MPN Center, and collaborators across Weill Cornell Medicine have discovered an innovative method to generate these blood-forming stem cells. Learn more about the implications for stem cell transplantation and curing patients with genetic and acquired blood diseases including MPNs.